In recent years, GLP-1 RA use has expanded to people with lower A1C and BMI levels at the time of prescription initiation and surged in popularity among individuals with both T2D and overweight/obesity (Gratzl et al., 2024)
This project was funded by start-up funds from Washington State University, Vancouver to A
10.7554/eLife.15092 eLife 26 SuzukiM.SuzukiM.KitamuraY.MoriS.SatoK.DohiS.et al (2002)
Canada meant to be the first big market after the patent expired stalled for most of the year, with Health Canada clearing no generic GLP-1 at all
Dong K, Pelle E, Yarosh DB, Pernodet N (2012) Sirtuin 4 identification in normal human epidermal keratinocytes and its relation to sirtuin 3 and energy metabolism under normal conditions and UVB-induced stress
These medications slow stomach emptying, reduce hunger signals, and improve insulin sensitivitynone of which directly interfere with the chemical pathways that blood thinners use